Salar Mousa: Effect of COVID-19 on Initiation of Antithrombotic Therapy Post-Stroke in Sweden
Salar Mousa, PHD Student at Örebro University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am very excited to share our newly published study examining the effect of COVID-19 pandemic on the initiation of antithrombotic therapy after stroke in Sweden.
Published in Basic and Clinical Pharmacology and Toxicology.
I would like to sincerely thank my supervisors and co-authors from Örebro University, Uppsala University and Gothenburg University for their support and work on this project.”
Title: Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre- and Post–COVID-19 in Sweden—An Interrupted Time Series Study
Authors: Salar Mousa, Katarina Persson, Maria Palmetun-Ekbäck, Fredrik Nyberg, Huiqi Li, Björn Wettermark, Mohammad Hossein Hajiebrahimi
Read the Full Article on Basic and Clinical Pharmacology and Toxicology
Stay updated on all scientific advances with Hemostasis Today.
-
May 23, 2026, 01:51Paula Greter: Access and Innovation in Hemophilia through ERAH2026
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance